Biofrontera Files sNDA to Broaden Ameluz PDT Label for Actinic Keratoses
Biofrontera has submitted an sNDA to the FDA seeking approval of Ameluz PDT for actinic keratoses on body areas beyond its currently labeled treatment sites.
Topic
Photodynamic Therapy
Topic
Photodynamic Therapy
FDA Approves Light-Based Therapy for a Common Skin Cancer
The FDA has approved a light-based treatment for a common skin cancer, adding a nonsurgical phototherapy option for non-melanoma…
Imiquimod Plus Cryotherapy Beats Phototherapy for Skin Cancer Precursor
A new study finds imiquimod combined with cryotherapy delivers longer-lasting clearance of skin cancer precursor lesions than pho…
FDA Approval of Ameluz Expands Skin Cancer Treatment Options
The FDA has approved Ameluz, a decision specialists hail as a meaningful addition to the skin cancer treatment armamentarium, Med…